- Home
- ORC vs XNCR Comparison
ORC vs XNCR Comparison
Compare ORC & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORC
- XNCR
- Stock Information
- Founded
- ORC 2010
- XNCR 1997
- Country
- ORC United States
- XNCR United States
- Employees
- ORC N/A
- XNCR N/A
- Industry
- ORC Real Estate Investment Trusts
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- ORC Real Estate
- XNCR Health Care
- Exchange
- ORC Nasdaq
- XNCR Nasdaq
- Market Cap
- ORC 660.1M
- XNCR 547.8M
- IPO Year
- ORC 2013
- XNCR 2013
- Fundamental
- Price
- ORC $7.10
- XNCR $8.62
- Analyst Decision
- ORC Hold
- XNCR Buy
- Analyst Count
- ORC 2
- XNCR 10
- Target Price
- ORC N/A
- XNCR $23.33
- AVG Volume (30 Days)
- ORC 4.2M
- XNCR 758.7K
- Earning Date
- ORC 10-23-2025
- XNCR 11-05-2025
- Dividend Yield
- ORC 20.28%
- XNCR N/A
- EPS Growth
- ORC N/A
- XNCR N/A
- EPS
- ORC 0.07
- XNCR N/A
- Revenue
- ORC $24,257,000.00
- XNCR $146,929,000.00
- Revenue This Year
- ORC $68.67
- XNCR $22.06
- Revenue Next Year
- ORC $51.70
- XNCR N/A
- P/E Ratio
- ORC $100.17
- XNCR N/A
- Revenue Growth
- ORC N/A
- XNCR N/A
- 52 Week Low
- ORC $5.69
- XNCR $6.92
- 52 Week High
- ORC $9.01
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- ORC 48.22
- XNCR 57.70
- Support Level
- ORC $7.12
- XNCR $8.26
- Resistance Level
- ORC $7.30
- XNCR $8.73
- Average True Range (ATR)
- ORC 0.11
- XNCR 0.38
- MACD
- ORC -0.00
- XNCR 0.06
- Stochastic Oscillator
- ORC 41.43
- XNCR 78.85
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.